Strategic Insight reports are designed to support strategic objectives and planning by Integrated Care System leaders. Through the analysis of data and communication with key stakeholders across the ICS, interventions to be undertaken by the ICS are proposed to Integrated Care Boards or associated committees.

This report combines primary and secondary care medicines usage data for antimicrobials. It supports ICBs in the consideration of system-wide ICS medicines data for a complete overview of system prescribing.